Bayer AG
XETRA:BAYN
Net Margin
Bayer AG
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Net Margin Comparison
Bayer AG Competitors
Country | DE |
Market Cap | 28.1B EUR |
Net Margin |
-6%
|
Country | JP |
Market Cap | 776 550.9T JPY |
Net Margin |
-79%
|
Country | US |
Market Cap | 748.7B USD |
Net Margin |
15%
|
Country | DK |
Market Cap | 3.9T DKK |
Net Margin |
36%
|
Country | UK |
Market Cap | 440.4B GBP |
Net Margin |
-4%
|
Country | US |
Market Cap | 381.9B USD |
Net Margin |
41%
|
Country | US |
Market Cap | 333B USD |
Net Margin |
1%
|
Country | UK |
Market Cap | 166.1B GBP |
Net Margin |
13%
|
Country | CH |
Market Cap | 182.8B CHF |
Net Margin |
20%
|
Country | CH |
Market Cap | 177.5B CHF |
Net Margin |
32%
|
Country | US |
Market Cap | 157.2B USD |
Net Margin |
4%
|
Net Margin Distribution
Net Margin Distribution
Pharmaceuticals Industry
Profitability Report
View the profitability report to see the full profitability analysis for Bayer AG.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Bayer AG's most recent financial statements, the company has Net Margin of -6.2%.